eiterates FY demand forecast, stock has had good run (trading +0.49%) • Novo Nordisk: FDA panel votes 8-4 to approve new ultra-long-lasting insulin Degludec (trading +8.3%) • IAG reports inline with estimates but FY loss much worse & cutting 4,500 jobs at Iberia (trading +1.7%) • Rolls Royce trading s